≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Open bite

Endpoint Browser PheWeb

K11_OPEN_BITE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Primary healthcare outpatient: ICD-10 — K07.24
  • Hospital discharge: ICD-10 — K07.24
  • Cause of death: ICD-10 — K07.24

3 out of 7 registries used, show all original rules.

2131

4. Check minimum number of events

None

2131

5. Include endpoints

None

2131

6. Filter based on genotype QC (FinnGen only)

2131

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF10

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 33503 19782 13652
Only index persons 28156 16874 11282
Unadjusted period prevalence (%)
Whole population 0.49 0.57 0.38
Only index persons 0.54 0.62 0.43
Median age at first event (years)
Whole population 12.86 13.55 11.78
Only index persons 14.52 15.12 13.62

-FinnGen-

Key figures

All Female Male
Number of individuals 2131 1605 526
Unadjusted period prevalence (%) 0.47 0.55 0.23
Median age at first event (years) 29.38 30.05 27.32

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1824
Matched controls
18241
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
SBB10
NOMESCO Finland
Teeth copy
11.8
323.0
965
1581
K07.24
ICD-10 Finland
Open bite
+∞
323.0
1824
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
13.5
322.3
611
654
K07.13
ICD-10 Finland
Retrognaty, mandibular
28.5
306.9
427
193
EB1MA
NOMESCO Finland
Cephalometry with X-ray
12.3
287.4
569
649
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
15.8
268.4
463
383
SJD00
NOMESCO Finland
Removal or reattacment of arrow in fixed orthodontisk device
10.1
243.2
535
721
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
7.0
231.9
679
1422
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
9.1
229.9
538
799
SJD10
NOMESCO Finland
Attachment of arrow to fixed orthodontisk device
9.4
225.7
516
734
K07.60
ICD-10 Finland
Snapping jaw
10.8
225.0
471
571
SAA04
NOMESCO Finland
Special inverstigation of mouth
8.2
211.8
532
873
EDC10
NOMESCO Finland
Sagittal osteotomy of ramus of mandible
63.2
203.7
237
43
SJC10
NOMESCO Finland
Orthodontic bandage in one tooth
9.8
201.8
445
583
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
14.5
201.2
357
301
SJD20
NOMESCO Finland
Attachment of modifiable arrow of fixed orthodontisk device
10.1
195.5
421
526
SJC50
NOMESCO Finland
Removal of orthodontisk device with at least 7 brackets
8.8
180.0
421
600
EEC05
NOMESCO Finland
Le Fort I osteotomy
112.8
178.1
192
19
SJX10
NOMESCO Finland
Short check-up visit for orthodontisk therapy
6.5
176.9
526
1067
SAA03
NOMESCO Finland
Extended examination of mouth
4.3
176.2
1326
6988
SJB00
NOMESCO Finland
Fitting of loose orthodontic device with user information
7.3
164.0
438
757
SJD40
NOMESCO Finland
Fixation of ready made palatinal or lingual arrow
7.2
158.5
428
748
SJD30
NOMESCO Finland
Demanding attachment of arrow to fixed orthodontisk device
10.2
148.7
313
363
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
9.1
134.9
304
394
SJC03
NOMESCO Finland
Positioning and fixed attachment of brackets, extensive
8.1
134.0
325
475
SXC05
NOMESCO Finland
Other oral or dental procedure
4.9
126.1
477
1227
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.3
123.5
960
4588
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.1
115.8
1120
6142
SJC00
NOMESCO Finland
Bracket with fixed attachment
74.3
110.1
125
18
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
5.3
107.8
368
831
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
21.4
106.1
159
81
K07.14
ICD-10 Finland
Retrognaty, maxillary
28.5
101.9
140
53
K07.30
ICD-10 Finland
Spacing, abnormal of tooth or teeth
5.1
94.0
330
760
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
26.3
92.6
130
53
K07.10
ICD-10 Finland
Asymmetry of jaw
46.2
92.0
113
26
SJX20
NOMESCO Finland
Check-up visit for orthodontisk therapy
5.8
92.0
286
571
SJA04
NOMESCO Finland
Very demanding plan for orthodontic care
63.0
92.0
107
18
SJB60
NOMESCO Finland
External device grinding and adaptation
6.3
91.9
264
477
SJC01
NOMESCO Finland
Positioning and fixed attachment of single bracket (Bracket with fixed attachment)
5.3
89.1
296
638
SJC02
NOMESCO Finland
Positioning and fixed attachment of brackets
6.7
87.3
238
400
K07.21
ICD-10 Finland
Anomalies of dental arch relationship
48.8
87.3
106
23
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
3.5
72.1
387
1295
SJC40
NOMESCO Finland
Removal of orthodontisk device with at most 6 brackets
4.5
70.1
273
687
SJA01
NOMESCO Finland
Estimation of need for orthodontic care
35.1
67.0
87
26
SJX21
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment
4.4
66.7
263
668
SJA03
NOMESCO Finland
Demanding plan for orthodontic care
78.3
66.6
75
10
K07.18
ICD-10 Finland
Another anomaly in the relationship between jaw and skull base
64.2
63.9
74
12
SAC03
NOMESCO Finland
Separate planning of oral and dental treatment, very demanding
14.0
63.0
110
83
SJX11
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment, restricted
3.8
63.0
298
892
EFB40
NOMESCO Finland
Removal of internal or external fixation device from facial bones
67.1
61.8
71
11
K07.11
ICD-10 Finland
Retrognathism (mandibular)(maxillary)
21.0
58.8
88
44
SAA02
NOMESCO Finland
Basic examination of mouth
2.6
55.3
1526
12137
K07.20
ICD-10 Finland
Crossbite (anterior)(posterior)
7.0
54.5
141
217
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
10.2
48.9
99
102
K07.22
ICD-10 Finland
Anomalies of dental arch relationship
8.9
47.5
104
123
EG1CG
NOMESCO Finland
Extensive MRI examination of mandipular joint with high intensity magnet
27.1
45.7
63
24
F45.8
ICD-10 Finland
Other somatoform disorders
3.2
44.4
264
928
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
4.3
44.0
176
447
SJD50
NOMESCO Finland
Production and attachment of palatinal or lingual arrow
7.3
43.8
109
158
M79.1
ICD-10 Finland
Myalgia
2.8
43.4
322
1306
EBB10
NOMESCO Finland
Insertion of dental implant
11.3
41.3
79
73
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
9.5
41.2
86
94
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
13.2
39.5
70
55
SDA02
NOMESCO Finland
Parodonthologic therapy
2.0
38.6
731
4611
EB1WA
NOMESCO Finland
NA
18.7
37.6
58
32
SJA02
NOMESCO Finland
Plan for orthodontic care
35.2
37.3
48
14
SXC03
NOMESCO Finland
Other oral or dental procedure
12.3
37.3
68
57
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
2.0
37.3
712
4487
SJB10
NOMESCO Finland
Fitting of loose orthodontic device with user information, demanding
5.1
36.9
121
250
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
3.4
36.3
187
588
K07.1
ICD-10 Finland
Anomalies of jaw-cranial base relationship
30.8
36.2
48
16
K07.61
ICD-10 Finland
Cracking jaw joint
5.5
35.3
108
206
EEC02
NOMESCO Finland
Rapid expansion of maxilla
183.5
34.9
36
*
SJF01
NOMESCO Finland
Assessment of need for orthodontic treatment
3.2
34.5
199
678
SAC02
NOMESCO Finland
Separate planning of oral and dental treatment, demanding
4.0
34.1
145
388
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.5
33.5
170
527
EG1AA
NOMESCO Finland
Mandibular joint X-ray examination
16.7
32.5
52
32
Z3229
NOMESCO Finland
Other healthcare associate professional
3.0
32.4
203
732
SAA01
NOMESCO Finland
Simple examination of mouth
2.0
32.1
1449
12069
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
14.5
30.2
51
36
K00.00
ICD-10 Finland
Hypodontia
5.5
30.0
91
172
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.2
30.0
119
299
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
6.6
30.0
79
125
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
7.8
29.9
70
93
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
8.4
29.7
66
81
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
12.1
29.0
53
45
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
28.5
616
3958
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.7
27.4
198
778
EBB15
NOMESCO Finland
Insertion of dental implant abutment
13.8
26.8
46
34
SJE90
NOMESCO Finland
Finishing face of orthodontick therapy
9.7
26.5
54
57
K07.04
ICD-10 Finland
Macrognathism (mandibular)(maxillary)
26.2
26.2
36
14
K07.62
ICD-10 Finland
Habitual dislocation of the jaw joint
10.1
26.0
52
53
SJX00
NOMESCO Finland
Reparation of orthodontiskt device by dentist
6.5
25.8
68
108
WZA90
NOMESCO Finland
Other doctors statement
1.8
25.7
545
3453
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.9
25.4
495
3046
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
8.3
25.2
56
69
K07.4
ICD-10 Finland
Malocclusion, unspecified
4.8
24.6
83
178
SAC01
NOMESCO Finland
Separate planning of oral and dental treatment, standard
3.1
24.5
145
502
P01BA02
ATC
hydroxychloroquine; oral
2.9
23.8
150
539
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
10.0
23.6
47
48
EDC30
NOMESCO Finland
Genioplasty
65.8
22.9
26
*
K07.23
ICD-10 Finland
Deep bite
2.7
22.7
167
661
EBA10
NOMESCO Finland
Surgical removal of tooth
1.9
22.3
366
2105
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
4.5
22.3
80
183
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
4.2
22.3
87
216
K01.0
ICD-10 Finland
Embedded teeth
3.8
22.0
95
258
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.1
21.4
124
424
ZXA10
NOMESCO Finland
Bilateral
2.0
21.4
291
1557
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
7.4
21.3
51
71
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.8
20.9
144
550
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.5
20.7
166
693
K03.64
ICD-10 Finland
Dental calculus supragingival
1.6
20.2
656
4649
OIKK
NOMESCO Finland
NA
2.4
20.2
185
827
A07EC01
ATC
sulfasalazine; oral, rectal
2.7
19.8
137
524
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.8
19.8
427
2681
EMAK
NOMESCO Finland
NA
3.2
19.7
107
350
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
19.6
210
1010
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
5.1
19.4
62
126
TEG10
NOMESCO Finland
Injection of diagnostic or therapeutic substance into mandibular joint
31.7
19.3
25
8
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
3.9
19.3
80
211
K07.55
ICD-10 Finland
Malocclusion caused by tongue, lip and finger habits
22.8
19.1
27
12
EGC30
NOMESCO Finland
Prosthetic replacement of mandibular joint
55.6
18.9
22
*
TEG00
NOMESCO Finland
Punction of mandibular joint
24.0
18.6
26
11
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
7.2
18.6
45
64
K05.30
ICD-10 Finland
Periodontitis complex
2.4
18.6
164
718
K06.00
ICD-10 Finland
Local gingivore traction
5.5
18.2
54
101
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
3.9
18.1
76
203
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.8
18.1
392
2457
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
3.8
17.7
76
207
K03.66
ICD-10 Finland
Tooth plaque
2.2
17.5
187
897
EGA05
NOMESCO Finland
Rinsing of mandipular joint
181.7
17.5
18
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
17.5
283
1607
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
12.2
16.8
30
25
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.5
16.7
130
533
ECB40
NOMESCO Finland
Surgical treatment of fracture of alveolus
10.5
16.7
32
31
EFB50
NOMESCO Finland
Orthodontic procedure connected with ortognathic surgery
+∞
16.7
16
*
K07.12
ICD-10 Finland
Prognathism (mandibular)(maxillary)
15.2
16.7
27
18
D19
ICPC
Teeth/gum symptom/complaint
1.6
16.5
542
3808
Z01.2
ICD-10 Finland
Dental examination
1.5
16.2
900
7143
K07.68
ICD-10 Finland
Other disorders of the jaw joint
7.1
16.1
39
56
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
16.1
440
2939
K03.00
ICD-10 Finland
Approximal wear
2.7
15.9
113
440
ZXX07
NOMESCO Finland
Extent of procedure, 7 units
60.5
15.8
18
*
Z96.5
ICD-10 Finland
Presence of tooth-root and mandibular implants
26.5
15.6
21
8
ECA70
NOMESCO Finland
Regenerative parodontal operation or gingiva and alveolus transplantation
19.4
15.6
23
12
SPC40
NOMESCO Finland
Preparation of first or second intermediate attachment tooth for bridge
16.2
15.2
24
15
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.9
14.8
90
317
K07.19
ICD-10 Finland
Anomalies in the relationship between jaw and skull base UNS
25.2
14.7
20
8
G47.3
ICD-10 Finland
Sleep apnoea
1.9
14.5
233
1318
K07.29
ICD-10 Finland
Anomaly in the relationship between the tooth arches UNS
36.3
14.4
18
5
SPB10
NOMESCO Finland
Production of temporary crone to tooth
9.2
14.2
29
32
R06.5
ICD-10 Finland
Mouth breathing
2.2
13.8
140
654
K07.6
ICD-10 Finland
Temporomandibular joint disorders
6.1
13.8
37
62
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.2
13.8
145
692
K07.27
ICD-10 Finland
Anomalies of dental arch relationship
3.5
13.6
62
179
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
2.6
13.6
99
391
K07.26
ICD-10 Finland
Anomalies of dental arch relationship
11.0
13.5
25
23
EB1TW
NOMESCO Finland
3D modelling of dentition
34.3
13.5
17
5
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.5
13.3
606
4548
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.4
12.8
801
6402
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
12.7
316
2043
K05.31
ICD-10 Finland
Periodontitis pronounced
2.4
12.7
104
440
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.0
12.6
72
244
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
3.5
12.5
58
170
L88
ICPC
Rheumatoid/seropositive arthritis
3.2
12.2
64
207
EBW99
NOMESCO Finland
Other operation on tooth
26.9
12.0
16
6
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.6
12.0
86
335
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.4
11.9
1093
9347
EGA00
NOMESCO Finland
Arthroscopy of mandibular joint
14.7
11.8
19
13
G50.1
ICD-10 Finland
Atypical facial pain
4.9
11.7
37
76
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.4
11.7
95
401
K07.03
ICD-10 Finland
Micrognatia (hypoplasia) of the upper jaw
16.5
11.7
18
11
K07.28
ICD-10 Finland
Another anomaly in the relationship between the dental arches
13.7
11.5
19
14
L04AA01
ATC
[U] ciclosporin; systemic
5.4
11.3
33
62
SPB20
NOMESCO Finland
Temporary bridge between two or more teeth
11.9
11.3
20
17
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
11.2
433
3115
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
11.2
489
3609
EB1BD
NOMESCO Finland
Extensive cone beam CT of teeth and jaws (two quarters)
15.6
10.8
17
11
ECA50
NOMESCO Finland
Parodontal operation
9.6
10.7
21
22
EG1DG
NOMESCO Finland
Very extensive MRI examination of mandipular joint with high intensity magnet
21.6
10.7
15
7
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
10.7
337
2311
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
10.6
295
1955
Z3226
NOMESCO Finland
Physiotherapist
1.6
10.6
295
1959
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.0
10.5
141
745
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.0
10.5
128
652
L04AB04
ATC
adalimumab; parenteral
3.5
10.4
47
136
EG1AD
NOMESCO Finland
CT of mandipular joint
110.6
10.4
11
*
EEC00
NOMESCO Finland
Segmental osteotomy of maxilla
+∞
10.4
10
*
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
3.9
10.2
40
103
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.5
10.2
340
2360
N03AX12
ATC
gabapentin; oral
1.8
9.9
172
996
H02AB09
ATC
hydrocortisone; systemic
2.7
9.9
67
256
KAY20
NOMESCO Finland
NA
2.3
9.9
92
417
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.3
9.9
86
377
R4110
NOMESCO Finland
Physiotherapy
1.5
9.7
359
2547
S03.0
ICD-10 Finland
Dislocation of jaw
5.2
9.7
29
57
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.2
9.7
49
156
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
9.7
460
3439
Z3231
NOMESCO Finland
Registered nurse
1.5
9.6
432
3189
R5140
NOMESCO Finland
Monitoring the use of the aid
2.1
9.6
104
502
ZXX05
NOMESCO Finland
Extent of procedure, 5 units
11.4
9.6
17
15
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.7
9.3
60
225
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
8.0
8.8
19
24
L04AB01
ATC
etanercept; parenteral
3.6
8.8
38
107
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.9
8.6
34
89
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.7
8.6
167
1001
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.6
8.6
259
1748
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
11.6
8.6
15
13
G47.8
ICD-10 Finland
Other sleep disorders
4.4
8.5
29
66
H02AB06
ATC
prednisolone; systemic
1.4
8.5
594
4745
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.7
8.5
56
213
KMAK
NOMESCO Finland
NA
1.3
8.5
851
7198
RK220
NOMESCO Finland
NA
6.4
8.5
21
33
OIKH
NOMESCO Finland
NA
2.0
8.4
105
542
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.7
8.3
161
967
K02.0
ICD-10 Finland
Caries limited to enamel
1.4
8.3
382
2825
H20.1
ICD-10 Finland
Chronic iridocyclitis
4.8
8.2
26
55
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
8.1
985
8550
M13.9
ICD-10 Finland
Arthritis, unspecified
2.0
8.1
100
513
XF404
NOMESCO Finland
Ambulatory ECG
2.0
8.0
101
523
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
1.8
7.9
135
777
K07.35
ICD-10 Finland
Impacted or embedded teeth with abnormal position of such teeth or adjacent teeth
3.2
7.9
39
123
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
7.9
884
7572
SJB30
NOMESCO Finland
Extraoral device arrangement and user information
2.8
7.9
47
168
WX110
NOMESCO Finland
Local anesthesy
1.3
7.9
1253
11304
SCA03
NOMESCO Finland
Preventive oral health care, extensive
1.8
7.9
126
712
N03AX16
ATC
pregabalin; oral
1.5
7.8
252
1731
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
6.4
7.7
19
30
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.5
7.7
285
2019
SJC20
NOMESCO Finland
Extraoral ofthodontisk pulling device arrangement and urser information
3.2
7.6
37
116
K07.01
ICD-10 Finland
Hyperplasia, hypoplasia mandibular
11.9
7.6
13
11
ECW06
NOMESCO Finland
Insertion of mini-implant or miniscrew
25.1
7.6
10
*
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
3.6
7.6
32
90
Z2446
NOMESCO Finland
Social worker
1.7
7.5
152
922
J02AC01
ATC
fluconazole; systemic
1.3
7.5
615
5020
KAY40
NOMESCO Finland
NA
1.9
7.5
101
536
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
7.5
553
4440
R01AD12
ATC
fluticasone furoate; nasal
1.4
7.4
541
4329
N03AF01
ATC
carbamazepine; oral, rectal
2.7
7.4
48
181
L04AA17
ATC
[U] adalimumab; parenteral
13.4
7.4
12
9
Z50.1
ICD-10 Finland
Other physical therapy
2.3
7.3
66
295
Z2445
NOMESCO Finland
Psychologist
1.8
7.3
126
727
M25.5
ICD-10 Finland
Pain in joint
1.4
7.3
409
3130
L04AB05
ATC
certolizumab pegol; parenteral
6.9
7.3
17
25
M01CB01
ATC
sodium aurothiomalate; parenteral
4.9
7.3
22
45
EBA00
NOMESCO Finland
Extraction of tooth
1.3
7.3
606
4947
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.6
7.3
192
1256
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
6.3
7.2
18
29
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
2.3
7.2
66
299
POLI
NOMESCO Finland
NA
20.1
7.1
10
5
R51.81
ICD-10 Finland
Facial pain NOS
3.0
7.1
37
123
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.5
7.0
290
2095
A02BC03
ATC
lansoprazole; oral
1.5
7.0
271
1936
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
3.2
6.9
34
108
P01AB01
ATC
metronidazole; oral, rectal
1.3
6.9
524
4210
SPAT1301
SPAT
No procedures
1.4
6.9
476
3769
J34.2
ICD-10 Finland
Deviated nasal septum
2.2
6.9
66
304
D82
ICPC
Teeth/gum disease
1.3
6.9
665
5537
K06.18
ICD-10 Finland
Another gingival hyperplasia
5.5
6.9
19
35
M01AE02
ATC
naproxen; oral, rectal
1.3
6.9
985
8665
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
6.9
131
781
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
13.8
6.9
11
8
ZYC01
NOMESCO Finland
Remote contact by phone
1.9
6.9
91
483
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.6
6.9
29
82
SAALT
NOMESCO Finland
NA
2.5
6.9
52
215
SDA05
NOMESCO Finland
Very demanding and lengthy parodonthologic therapy
2.0
6.8
82
418
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.7
6.8
152
951
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
5.0
6.8
20
40
SPA40
NOMESCO Finland
Precision impression for dental prosthesis
11.0
6.8
12
11
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
6.8
298
2181
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.0
6.8
37
127
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
6.1
6.8
17
28
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
6.8
353
2668
5241A
ICD-9 Finland
Dentofacial anomalies, including malocclusion, Anomalies of relationship of jaw to cranial base
40.2
6.8
8
*
K06.10
ICD-10 Finland
Gingival fibromatosis
16.7
6.7
10
6
A02BC01
ATC
omeprazole; systemic
1.4
6.7
304
2236
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.8
6.7
116
673
OIKAL
NOMESCO Finland
NA
2.3
6.7
60
271
Z2221
NOMESCO Finland
Medical doctor
1.4
6.7
428
3346
EBA12
NOMESCO Finland
Complicated surgical removal of tooth
1.9
6.7
89
473
-2
ICD-10 Finland
NA
2.0
6.6
74
370
F82
ICD-10 Finland
Specific developmental disorder of motor function
3.0
6.6
34
113
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
4.4
6.5
22
51
SPC25
NOMESCO Finland
Other demanding attachment of crone of tooth
10.1
6.5
12
12
M01AH01
ATC
celecoxib; oral (coxibs)
1.6
6.5
163
1050
R01AD08
ATC
fluticasone; nasal
1.4
6.5
418
3272
EEW99
NOMESCO Finland
Other operation on maxilla
70.1
6.4
7
*
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
4.3
6.4
22
52
EG1CM
NOMESCO Finland
Mandipular joint extensive MRI examination with 3 Tesla magnet
14.4
6.4
10
7
XX7LW
NOMESCO Finland
NA
14.4
6.4
10
7
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.9
6.3
88
475
B03XA01
ATC
erythropoietin; parenteral
5.5
6.3
17
31
RD210
NOMESCO Finland
NA
2.2
6.3
62
292
L04AX01
ATC
azathioprine; systemic
2.0
6.3
78
405
YEA05
NOMESCO Finland
Excision of gingival or connective tissue for transplantation
18.1
6.3
9
5
K03.29
ICD-10 Finland
Erosion of teeth occupational
3.4
6.2
28
84
EEC99
NOMESCO Finland
Other reconstructive operations on maxilla
26.8
6.2
8
*
-1
NOMESCO Finland
NA
1.3
6.2
729
6214
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.8
6.2
93
516
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
4.1
6.2
22
54
SPC30
NOMESCO Finland
Tooth bridge attacment with resins
6.3
6.2
15
24
L04AA13
ATC
leflunomide; oral
2.8
6.1
36
129
S02.62
ICD-10 Finland
Fracture of the condyle of the lower jaw
7.7
6.1
13
17
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
6.1
536
4388
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
6.1
241
1728
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
6.1
234
1666
KAC00
NOMESCO Finland
Nephrectomy
6.7
6.0
14
21
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.5
6.0
239
1713
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.3
6.0
52
230

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
902
6719
1.59
23.35
3.2
2.5
nmol/l
76.3
71.6
5.64
847
6298
(3019309) Folate [Moles/volume] in Red Blood Cells
283
1758
1.70
14.25
1.6
1.6
nmol/l
1230.5
1179.0
0.33
216
1380
(3019198) Lymphocytes [#/volume] in Blood
1088
9122
1.39
12.54
8.8
6.5
e9/l
2.0
2.0
0.65
1009
8169
(3013707) Erythrocyte sedimentation rate by Westergren method
1366
11922
1.41
12.29
5.2
3.8
mm/h
8.2
8.8
1.57
1297
11134
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1292
11232
1.38
11.49
7.2
6.3
u/l
77.9
79.6
0.62
1223
10588
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
354
2446
1.54
11.38
1.5
1.6
pmol/l
13968721.3
32035661.0
0.52
315
2157
(3018010) Neutrophils/100 leukocytes in Blood
1022
8592
1.36
11.02
8.6
6.3
%
54.5
54.9
0.57
986
8148
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
532
4013
1.43
10.98
2.4
2.4
mg/l
2.7
2.7
0.19
464
3495
(3006315) Basophils [#/volume] in Blood
1039
8769
1.36
10.87
9.1
6.5
e9/l
0.0
0.0
0.02
949
7673
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1561
14103
1.40
10.35
4.8
3.9
pmol/l
14.5
14.4
2.16
1449
13047
(3001604) Monocytes [#/volume] in Blood
1032
8748
1.35
10.27
9.1
6.5
e9/l
0.5
0.5
0.72
950
7656
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
402
2914
1.47
10.16
1.3
1.3
iu/ml
20.1
25.4
0.61
127
867
(3013115) Eosinophils [#/volume] in Blood
1064
9074
1.34
10.11
9.6
6.9
e9/l
0.2
0.2
1.18
983
8083
(3037467) Urinalysis macro (dipstick) panel - Urine
1323
11663
1.35
10.06
5.1
3.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
992
8378
1.34
10.03
3.8
3.1
estimate
0.0
0.0
0.80
212
1683
(3009261) Glucose [Presence] in Urine by Test strip
998
8469
1.34
9.63
3.8
3.1
estimate
0.0
0.0
0.80
217
1703
(3002030) Lymphocytes/100 leukocytes in Blood
1023
8718
1.33
9.57
9.0
6.4
%
31.4
31.0
0.66
985
8241
(3017181) Myelocytes/100 leukocytes in Blood
199
1256
1.64
9.35
5.4
4.3
%
0.8
0.9
0.06
53
312
(3037522) Nuclear Ab [Titer] in Serum
353
2535
1.47
9.30
1.5
1.4
titre
672.4
538.7
0.44
68
469
(3021601) Nitrite [Presence] in Urine by Test strip
988
8402
1.33
9.27
5.1
4.3
estimate
0.0
0.0
0.41
220
1752
(3006504) Eosinophils/100 leukocytes in Blood
973
8258
1.33
9.25
9.2
6.5
%
2.8
2.9
0.38
929
7759
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
790
6514
1.34
9.13
3.8
3.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1087
9391
1.32
9.03
3.3
3.0
ug/l
81.2
68.5
0.30
1042
8886
(3019069) Monocytes/100 leukocytes in Blood
977
8317
1.32
9.01
9.5
6.7
%
8.1
8.1
0.42
940
7872
(3013650) Neutrophils [#/volume] in Blood by Automated count
1137
9895
1.32
8.92
11.2
8.7
e9/l
3.6
3.9
3.14
1045
8640
(3021440) Promyelocytes/100 leukocytes in Blood
190
1202
1.64
8.84
5.5
4.4
%
0.1
0.1
0.35
47
288
(3009214) Lutropin [Units/volume] in Serum or Plasma
170
1051
1.67
8.66
1.7
1.6
u/l
7.5
8.4
0.61
134
818
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
376
2768
1.44
8.65
1.3
1.3
u/ml
9.1
9.6
0.05
151
1133
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1731
16074
1.41
8.56
5.5
4.5
mu/l
1.8
2.0
0.96
1646
15199
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
791
6573
1.32
8.50
9.2
6.8
mmol/l
1.2
1.2
0.21
682
5647
(3022096) Basophils/100 leukocytes in Blood
936
7969
1.31
8.43
9.3
6.6
%
0.7
0.7
0.62
898
7510
(3002179) Metamyelocytes/100 leukocytes in Blood
183
1164
1.63
8.34
4.7
4.1
%
0.9
0.5
0.38
30
233
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
70
338
2.11
7.75
4.7
7.6
%
1.6
1.7
0.25
65
310
(3025159) Blasts/100 leukocytes in Blood
179
1155
1.60
7.70
5.6
4.4
%
0.1
0.0
0.07
35
246
(40760892) CBC W Ordered Manual Differential panel - Blood
537
4293
1.34
7.35
5.7
4.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
691
5733
1.30
7.24
9.0
6.7
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
68
336
2.06
7.11
4.6
7.7
%
0.9
0.9
0.38
63
312
(3036481) Cortisol [Moles/volume] in Serum or Plasma
249
1759
1.47
7.07
2.5
2.1
nmol/l
353.1
375.2
1.06
234
1628
(3041096) Erythrocytes [Presence] in Urine by Automated
601
4914
1.31
6.96
3.3
2.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
219
1513
1.50
6.94
1.3
1.3
u/ml
142.0
262.1
3.05
206
1406
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
436
3417
1.35
6.76
2.6
2.1
u/l
160.1
212.7
1.18
410
3254
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
544
4408
1.31
6.69
2.5
2.5
u/l
57.7
55.7
0.30
503
4087
(3017446) Testosterone [Moles/volume] in Serum or Plasma
159
1046
1.56
6.32
2.7
2.0
nmol/l
10.5
10.4
0.04
134
915
(3022948) Iron [Moles/volume] in Serum or Plasma
297
2227
1.39
6.05
2.9
2.4
umol/l
14.6
14.6
0.07
283
2068
(3021960) Folate [Moles/volume] in Serum or Plasma
346
2660
1.36
6.04
1.5
1.4
nmol/l
21.0
20.1
0.59
298
2369
(3024561) Albumin [Mass/volume] in Serum or Plasma
654
5495
1.27
5.98
5.6
5.1
g/l
37.3
37.2
0.23
612
5138
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
95
558
1.74
5.91
2.1
2.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
544
4472
1.29
5.90
4.2
3.3
estimate
0.0
0.0
1.49
214
1714
(3010375) cycloSPORINE [Mass/volume] in Blood
29
107
2.73
5.86
47.7
32.0
ug/l
125.3
128.6
0.08
24
97
(3013512) EKG study
391
3079
1.33
5.80
2.9
2.7
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
18
50
3.62
5.76
3.6
5.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
213
1520
1.45
5.74
1.6
1.5
iu/l
17.2
19.5
0.55
171
1224
(3004789) Transferrin [Mass/volume] in Serum or Plasma
268
2002
1.39
5.58
2.9
2.4
g/l
2.5
2.5
0.16
252
1852
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
696
5934
1.26
5.54
9.6
6.5
mmol/l
1.2
1.2
0.14
639
5487
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
145
965
1.54
5.51
7.5
5.1
ng/l
66.9
67.1
0.02
139
899
(3021589) Normoblasts [#/volume] in Blood
914
8042
1.24
5.47
10.4
8.5
e9/l
0.0
0.0
0.93
787
6560
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
582
4867
1.27
5.44
1.9
1.7
pmol/l
99.1
98.0
0.25
308
2668
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
19
57
3.35
5.44
11.3
7.9
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
181
1267
1.47
5.40
2.9
3.3
pmol/l
4.6
4.7
0.13
163
1135
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
34
4.14
5.36
7.9
8.0
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1861
17787
1.37
5.34
12.1
10.2
umol/l
67.2
67.5
0.34
1861
17779
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
15
39
3.87
5.26
5.9
6.4
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
15
39
3.87
5.26
5.9
6.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
806
7038
1.23
5.07
5.2
5.5
umol/l
10.0
10.7
0.99
754
6572
(3032080) INR in Blood by Coagulation assay
524
4361
1.27
5.05
5.2
5.3
inr
1.1
1.1
1.00
165
1484
(40761511) CBC panel - Blood by Automated count
1928
18566
1.40
4.99
11.3
9.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
241
1807
1.38
4.91
1.2
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
16
48
3.35
4.60
5.9
3.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1219
11169
1.21
4.58
4.6
3.8
e6/l
505.9
749.3
0.18
14
111
(3013826) Glucose [Moles/volume] in Serum or Plasma
959
8589
1.21
4.54
5.5
4.4
mmol/l
6.2
6.2
0.18
865
7785
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
270
2086
1.34
4.54
3.9
3.2
ng/l
440.6
627.2
1.68
217
1669
(3041806) Other cells [#/volume] in Blood by Manual count
45
228
1.99
4.51
1.4
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
639
5501
1.23
4.48
1.5
1.4
u/ml
2.5
1.7
0.76
180
1405
(3019150) Specific gravity of Urine by Refractometry
449
3729
1.26
4.34
3.8
3.2
kg/l
1.0
1.0
0.24
59
541
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
239
1826
1.35
4.33
3.1
2.5
%
23.7
23.7
0.02
208
1606
(3015377) Calcium [Moles/volume] in Serum or Plasma
524
4432
1.24
4.31
2.8
2.9
mmol/l
2.4
2.4
0.22
458
4019
(3023520) Reticulocytes [#/volume] in Blood
133
918
1.48
4.30
3.7
3.7
e9/l
59.6
70.0
3.91
107
641
(3026389) Candida sp identified in Specimen by Organism specific culture
48
255
1.90
4.22
1.2
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
99
647
1.56
4.15
4.9
3.3
ng/l
141.8
120.3
0.16
91
569
(3023103) Potassium [Moles/volume] in Serum or Plasma
1724
16438
1.26
4.09
11.9
10.1
mmol/l
3.9
3.9
0.75
1667
15888
(3027945) Reticulocytes/100 erythrocytes in Blood
182
1346
1.39
4.05
6.4
4.2
%
1.4
1.6
4.71
169
1231
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
483
4077
1.24
4.02
2.4
2.6
ng/l
32.0
31.6
0.02
225
1829
(3048689) Calprotectin [Mass/mass] in Stool
366
2994
1.27
4.00
3.2
2.8
ug/g
157.0
106.8
1.06
298
2362
(3008152) Bicarbonate [Moles/volume] in Arterial blood
83
529
1.59
3.89
8.6
8.1
mmol/l
24.7
24.2
0.51
78
493
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1548
14622
1.21
3.85
3.5
3.2
mmol/l
5.5
5.6
2.21
1440
13644
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1830
17612
1.28
3.75
12.0
10.0
mg/l
18.0
19.9
2.00
1397
13119
(3016244) Insulin [Units/volume] in Serum or Plasma
51
288
1.79
3.74
3.6
3.3
mu/l
14.8
27.1
2.42
51
272
(3020393) Adenovirus Ag [Presence] in Stool
20
78
2.58
3.72
2.1
2.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
72
449
1.62
3.70
1.6
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
72
450
1.62
3.67
1.4
1.2
u/ml
3.6
10.4
—
10
79
(44806118)
43
232
1.87
3.65
1.9
1.7
—
—
—
0
0
(44790049)
43
232
1.87
3.65
1.9
1.7
—
—
—
0
0
(44790047)
43
232
1.87
3.65
1.9
1.7
—
—
—
0
0
(44790048)
43
232
1.87
3.65
1.9
1.7
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
40
3.26
3.62
2.4
3.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
195
1487
1.34
3.60
9.3
6.5
mmol/l
1.7
1.5
0.53
160
1205
(3052851) Hemolysis interference index of Serum or Plasma
68
422
1.63
3.57
2.8
2.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
867
7827
1.18
3.47
4.3
4.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
28
132
2.14
3.46
1.5
1.6
%
25.7
53.5
3.60
20
90
(3018133) Calcium [Moles/volume] in Urine
24
106
2.28
3.45
2.1
3.1
mmol/l
2.8
2.6
0.29
24
100
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
46
259
1.79
3.44
1.5
1.4
umol/l
5.0
5.8
0.74
40
242
(3007853) Bacteria identified in Skin by Aerobe culture
241
1908
1.30
3.42
1.8
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1378
12937
1.18
3.41
4.4
4.0
mmol/mol
36.7
37.4
2.08
1310
12255
(3019550) Sodium [Moles/volume] in Serum or Plasma
1713
16405
1.23
3.41
12.0
10.0
mmol/l
139.6
139.5
0.38
1665
15902
(3025941) Bacteria identified in Stool by Culture
152
1127
1.38
3.37
1.3
1.2
—
—
—
0
0
(3019225) pH of Specimen
147
1084
1.38
3.37
3.3
3.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
62
383
1.64
3.34
10.6
7.1
iu/ml
590.0
331.5
—
7
51
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
70
446
1.59
3.33
1.4
1.2
u/ml
11.1
3.0
—
10
49
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
245
1956
1.29
3.27
1.7
1.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
79
521
1.54
3.25
2.3
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
182
1397
1.33
3.24
5.2
4.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
16
60
2.68
3.22
1.1
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
223
1762
1.30
3.22
1.5
1.5
—
—
—
0
0
(4010399)
128
932
1.40
3.18
1.5
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
126
916
1.40
3.16
1.6
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
516
4483
1.20
3.15
2.6
2.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
46
267
1.74
3.13
1.6
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
369
3106
1.23
3.11
3.3
2.6
e6/l
6.0
8.1
2.15
326
2720
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
226
1798
1.29
3.10
1.2
1.2
iu/ml
87.5
154.6
3.00
96
677
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
417
3556
1.21
3.09
1.7
1.6
mmol/l
1.3
1.3
1.27
374
3135
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
23
105
2.20
3.09
2.3
3.0
mg/l
9.6
10.4
0.29
17
91
(3037121) Protein [Mass/volume] in Urine
87
594
1.48
3.06
4.6
4.9
g/l
0.2
0.4
1.52
48
332
(3008898) HLA-B27 [Presence]
134
991
1.38
3.04
1.1
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
21
93
2.27
3.03
3.1
5.2
umol/l
205.1
159.9
0.20
15
57
(3035637) Corticotropin [Mass/volume] in Plasma
50
301
1.68
3.00
1.6
1.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1852
17939
1.25
2.98
10.4
8.2
u/l
25.2
25.4
0.18
1797
17387
(3022145) Colonoscopy Study observation
193
1514
1.30
2.96
1.5
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
153
1169
1.33
2.84
2.6
2.2
e9/l
3.9
4.1
0.42
127
1006
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
52
322
1.63
2.82
1.5
1.3
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
25
123
2.04
2.81
5.4
4.0
ug/l
1.6
1.6
0.08
25
118
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
74
498
1.50
2.81
2.4
1.6
u/ml
83.0
100.1
0.77
13
75
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
62
402
1.56
2.79
1.1
1.2
u/ml
28.9
31.1
—
7
34
(3002385) Erythrocyte distribution width [Ratio]
1646
15794
1.19
2.75
15.5
12.4
%
13.3
13.3
0.14
1620
15491
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
52
325
1.62
2.73
1.2
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
87
609
1.45
2.73
3.8
2.6
e6/l
0.1
0.1
0.01
82
589
(3003458) Phosphate [Moles/volume] in Serum or Plasma
237
1929
1.26
2.72
12.0
7.3
mmol/l
1.1
1.1
0.02
224
1831
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
58
373
1.57
2.71
1.8
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
612
5460
1.17
2.69
3.3
3.3
u/l
29.1
29.5
0.15
583
5203
(1761482) Bacteria [#/volume] in Urine by Culture
41
242
1.71
2.67
2.8
2.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
139
1058
1.34
2.66
3.8
3.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
36
205
1.77
2.66
1.6
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
176
1386
1.29
2.64
3.6
2.9
g/l
10.1
10.2
0.03
162
1291
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1503
14334
1.16
2.64
3.4
3.0
mmol/l
1.1
1.2
2.91
1432
13580
(3011397) Hemoglobin [Presence] in Urine by Test strip
441
3843
1.19
2.57
3.8
3.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
83
585
1.44
2.53
1.6
1.8
g/l
0.2
0.2
1.54
76
553
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
13
50
2.61
2.53
1.8
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
13
50
2.61
2.53
1.8
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
13
50
2.61
2.53
1.8
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
209
1693
1.26
2.51
4.1
3.7
umol/l
5.6
6.5
0.49
169
1407
(3019060) Gas panel - Arterial blood
78
545
1.45
2.49
6.2
6.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
168
1327
1.29
2.48
1.8
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
413
3592
1.19
2.46
2.2
2.1
mg/l
0.8
0.9
1.06
302
2592
(3020874) Milk IgE Ab [Units/volume] in Serum
41
249
1.66
2.44
1.0
1.2
u/ml
3.6
3.1
0.04
16
114
(3004809) Band form neutrophils/100 leukocytes in Blood
33
189
1.76
2.41
4.5
3.2
%
1.4
1.1
0.20
24
150
(40768443) Skin Pathology biopsy report
74
516
1.45
2.40
1.3
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
73
508
1.45
2.40
1.1
1.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
42
258
1.64
2.39
1.8
1.9
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
64
434
1.49
2.39
1.5
1.4
u/l
17.6
17.0
0.06
55
377
(3028026) IgM [Mass/volume] in Serum or Plasma
136
1051
1.31
2.37
1.7
1.9
g/l
1.1
1.2
0.83
129
991
(3030905) Polymorphonuclear cells [#/volume] in Blood
53
346
1.55
2.36
3.4
3.9
e9/l
3.0
3.9
3.52
53
346
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
127
974
1.32
2.34
1.4
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
30
169
1.79
2.33
1.7
1.4
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
84
604
1.41
2.32
1.6
1.8
g/l
1.1
1.2
1.07
76
571
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
86
621
1.40
2.32
1.6
1.6
iu/ml
0.1
0.2
0.50
19
119
(3008757) Leukocyte morphology finding [Identifier] in Blood
29
163
1.79
2.27
4.5
4.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
232
1925
1.23
2.27
1.9
1.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1568
15064
1.15
2.26
3.8
3.3
mmol/l
4.6
4.7
2.68
1501
14326
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1577
15159
1.16
2.25
3.9
3.5
mmol/l
2.8
2.8
3.23
1499
14303
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
75
535
1.42
2.18
2.3
2.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1558
14976
1.15
2.17
3.8
3.3
mmol/l
1.5
1.5
0.38
1484
14188
(3018677) aPTT in Platelet poor plasma by Coagulation assay
240
2008
1.22
2.17
3.5
3.0
s
29.1
29.6
0.84
230
1953
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
56
378
1.49
2.16
1.9
1.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
53
354
1.51
2.15
3.6
4.2
%
48.7
55.2
3.31
53
354
(3026782) Osmolality of Urine
336
2908
1.18
2.12
3.1
2.7
mosm/kgh2o
548.5
564.0
0.55
293
2497
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
13
55
2.37
2.12
1.0
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
154
1233
1.27
2.08
3.5
4.5
u/l
248.0
239.2
0.20
145
1184
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
162
1305
1.26
2.08
3.5
3.2
g/l
0.2
0.2
0.14
151
1236
(3045424) Erythrocytes [Presence] in Urine
41
261
1.58
2.07
1.5
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
36
222
1.63
2.06
2.8
3.2
e9/l
1.1
1.3
0.73
23
142
(3034274) Bile acid [Moles/volume] in Serum --fasting
89
664
1.36
2.01
2.5
2.8
umol/l
5.9
6.2
0.14
58
511
(3017354) Segmented neutrophils/100 leukocytes in Blood
21
111
1.90
2.01
2.7
3.0
%
58.7
57.1
0.11
12
74
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
88
656
1.36
2.00
2.1
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
37
232
1.61
1.99
1.8
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
15
70
2.15
1.98
1.1
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2040
20112
1.34
1.98
18.8
14.8
e9/l
263.4
264.3
0.24
2004
19577
(42529582) MDA5 Ab [Presence] in Serum by Line blot
9
33
2.73
1.93
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
9
33
2.73
1.93
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
9
33
2.73
1.93
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
9
33
2.73
1.93
1.0
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
66
472
1.41
1.93
2.1
1.6
nmol/l
45.4
41.0
0.34
66
462
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
175
1437
1.24
1.92
4.1
3.1
%
32.2
32.3
0.04
125
1075
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
160
1301
1.25
1.92
1.7
1.7
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
33
204
1.63
1.89
2.8
3.2
%
51.2
44.6
—
5
18
(3022313) Gas panel - Capillary blood
121
953
1.29
1.89
14.2
5.9
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
14
65
2.16
1.88
5.0
3.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
357
3139
1.16
1.87
1.8
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
54
375
1.45
1.85
1.4
1.4
ug/g
307.7
326.3
0.27
24
196
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
16
79
2.03
1.85
2.8
3.2
ug/l
27.3
25.9
0.06
16
79
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
87
657
1.34
1.84
4.4
4.4
g/l
3.2
3.3
0.09
80
628
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
12
4.17
1.82
1.0
1.5
ng/l
72.2
95.7
—
5
12
(3000475) Leukocytes [#/volume] in Synovial fluid
39
254
1.55
1.82
1.9
1.6
e6/l
7681.2
10515.4
0.37
32
192
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
14
66
2.13
1.82
2.9
2.3
umol/l
14.9
17.0
0.35
14
66
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
111
1404
0.78
1.81
2.2
2.3
u/l
37.5
73.3
0.51
96
1178
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
31
191
1.63
1.81
3.0
3.2
e9/l
0.2
0.2
0.45
26
160
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
31
191
1.63
1.81
2.9
3.1
%
9.4
10.2
0.26
21
139
(3018418) pH of Serum or Plasma
411
3662
1.15
1.80
4.3
3.5
ph
7.4
7.4
0.98
76
718
(3020630) Protein [Mass/volume] in Serum or Plasma
94
721
1.32
1.79
1.6
2.4
g/l
67.3
67.3
0.01
89
678
(40758558) Short blood count panel - Blood
489
4412
1.14
1.79
8.9
7.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
545
4953
1.13
1.78
2.4
2.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
2040
20134
1.31
1.76
18.7
14.7
fl
89.3
89.1
0.83
2022
19884
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
19
102
1.87
1.76
1.6
1.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
31
193
1.62
1.75
3.0
3.2
e6/l
422.5
510.8
0.93
26
159
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
694
6408
1.12
1.75
1.8
1.8
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
173
1435
1.22
1.74
1.7
1.6
mu/l
333.7
313.8
0.26
157
1284
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
12
54
2.23
1.74
1.0
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
2041
20148
1.31
1.73
18.8
14.8
e9/l
6.5
6.7
3.44
2006
19575
(3035941) MCH [Entitic mass]
2040
20137
1.31
1.73
18.7
14.7
pg
29.9
29.8
0.77
2022
19888
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
120
1491
0.79
1.70
2.2
1.9
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
2040
20140
1.30
1.70
18.8
14.7
e12/l
4.5
4.6
0.49
2005
19577
(3000963) Hemoglobin [Mass/volume] in Blood
2041
20152
1.30
1.70
18.9
14.8
g/l
134.9
135.1
0.18
2026
19906
(3016502) Oxygen saturation in Arterial blood
115
916
1.27
1.67
11.3
9.1
%
96.2
96.3
0.05
110
885
(3044889) 12 lead EKG panel
998
9423
1.11
1.66
2.8
2.7
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
23
134
1.72
1.66
1.3
1.2
ratio
1.0
1.0
—
7
60
(3032057) Clostridioides difficile [Presence] in Stool
6
19
3.16
1.66
2.3
1.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1514
14623
1.12
1.65
8.5
8.0
ml/min/173m2
96.6
96.5
0.05
1228
11408
(3009508) Creatinine [Moles/volume] in Urine
438
3955
1.14
1.58
3.4
3.5
mmol/l
7.9
8.3
1.02
391
3505
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
26
2.70
1.58
1.0
1.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
83
639
1.31
1.58
2.2
1.5
u/ml
173.8
213.7
0.84
43
351
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
18
99
1.83
1.57
1.4
1.1
%
90.0
92.4
—
8
51
(36660697) Celiac disease serology panel - Serum
233
2015
1.18
1.52
1.2
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
20
115
1.75
1.52
4.1
3.9
—
—
—
0
0
(3036489) Thrombin time
95
749
1.28
1.52
3.9
3.7
s
21.6
21.7
0.02
79
661
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
86
670
1.30
1.51
1.8
2.0
ug/l
5.0
6.6
0.59
79
595
(3027801) Oxygen [Partial pressure] in Arterial blood
128
1047
1.24
1.50
10.5
8.4
kpa
13.6
13.7
0.05
123
1003
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
128
1048
1.24
1.49
10.6
8.4
kpa
5.0
5.1
0.25
123
1003
(40768804) Tissue Pathology biopsy report
649
6017
1.11
1.49
2.0
1.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
27
170
1.60
1.49
1.6
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
160
1344
1.21
1.46
13.7
9.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
9
38
2.37
1.45
1.6
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
24
148
1.63
1.44
13.8
14.3
nmol/l
816.8
805.1
0.04
24
142
(3003327) Ova and parasites identified in Stool by Light microscopy
104
836
1.26
1.44
1.6
1.7
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
17
95
1.80
1.43
1.5
1.1
%
88.1
89.4
—
7
48
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
418
3793
1.13
1.40
2.3
2.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
83
652
1.28
1.39
3.8
4.1
%
158.1
162.8
0.24
75
635
(3014599) Egg white IgE Ab [Units/volume] in Serum
36
247
1.47
1.38
1.1
1.2
u/ml
0.8
7.0
1.88
13
100
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
16
89
1.80
1.37
5.1
1.9
u/field
1.1
3.2
2.04
11
53
(3033705) Calcium.ionized [Moles/volume] in Venous blood
16
89
1.80
1.37
2.0
2.5
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
6
23
2.61
1.36
1.0
1.0
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
6
23
2.61
1.36
1.0
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
19
112
1.70
1.35
2.1
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
240
2103
1.16
1.35
2.8
3.0
ng/l
176.7
624.3
3.27
122
1135
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
83
655
1.28
1.35
1.1
1.1
u/ml
2.8
6.7
1.11
15
96
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
29
192
1.52
1.32
1.7
1.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
518
4775
1.11
1.31
1.5
1.5
g/l
1.9
2.0
0.41
337
2891
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
31
209
1.49
1.30
3.5
3.9
u/ml
75.2
142.9
—
7
64
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
29
193
1.51
1.29
2.1
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
38
268
1.43
1.28
2.4
2.8
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
16
92
1.74
1.25
2.0
2.5
mmol/l
105.7
106.0
0.14
16
92
(3013293) Extractable nuclear Ab [Presence] in Serum
6
25
2.40
1.24
1.0
2.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
25
2.40
1.24
1.2
6.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
118
981
1.21
1.23
4.0
3.6
mmol/l
1.2
1.2
0.03
109
842
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
45
2.00
1.23
1.0
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
45
2.00
1.23
1.0
1.4
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
31
212
1.47
1.23
1.1
1.1
u/ml
0.4
3.1
—
8
38
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
89
719
1.25
1.21
6.0
4.4
%
96.1
93.5
0.63
82
671
(3017569) Oxygen content in Arterial blood
8
37
2.17
1.21
2.4
3.9
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
16
93
1.73
1.21
2.0
2.5
mmol/l
3.8
3.9
0.62
16
93
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
27
180
1.51
1.21
3.2
3.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
22
140
1.58
1.20
3.5
3.4
e6/l
328.0
259.7
0.29
15
99
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
13
71
1.84
1.19
1.1
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
27
181
1.50
1.18
2.8
2.9
e6/l
683.6
850.0
—
9
49
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
8
38
2.11
1.18
1.6
1.9
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
132
1115
1.20
1.18
1.2
1.2
au/ml
58.7
37.3
—
5
45
(40759836) Histone Ab [Presence] in Serum by Immunoblot
24
157
1.53
1.17
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
24
157
1.53
1.17
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
24
157
1.53
1.17
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
24
157
1.53
1.17
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
24
157
1.53
1.17
1.1
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
23
149
1.55
1.17
3.9
3.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
22
141
1.57
1.17
1.1
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
330
2988
1.12
1.16
3.4
3.9
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
20
2.50
1.15
1.6
3.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
604
5649
1.10
1.14
4.5
3.6
e6/l
58.2
62.3
0.09
417
3680
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
24
158
1.52
1.14
1.1
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
27
183
1.48
1.13
1.3
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
298
2687
1.13
1.13
1.7
1.7
%
1.4
1.4
0.23
267
2444
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
35
250
1.41
1.13
1.3
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
336
3052
1.12
1.12
3.1
2.5
umol/l
2334.4
3405.4
0.31
300
2749
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
55
423
1.31
1.12
1.7
2.2
g/l
1.2
1.3
0.32
48
380
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
7
30
2.34
1.12
5.4
9.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
405
3718
1.11
1.12
1.6
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
36
259
1.40
1.11
6.3
3.7
mmol/l
3.8
3.8
0.11
36
241
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
221
1956
1.14
1.11
2.0
2.4
mmol/l
2.4
2.4
0.28
199
1701
(21494814) CD8 cells/100 lymphocytes in Specimen
10
51
1.97
1.11
1.4
2.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
27
184
1.47
1.11
1.3
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1663
16263
1.10
1.11
3.9
3.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
552
5150
1.10
1.10
2.3
2.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
7
31
2.26
1.10
1.0
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
32
2.19
1.08
5.1
3.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
450
4162
1.10
1.08
3.7
3.0
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
16
97
1.65
1.06
1.1
1.1
%
95.6
87.2
0.55
16
80
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
27
186
1.46
1.06
1.3
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
17
105
1.62
1.06
1.1
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
17
105
1.62
1.06
1.1
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
17
105
1.62
1.06
1.1
1.6
—
—
—
0
0
(4281824)
6
122
0.49
1.05
1.0
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
5
22
2.28
1.03
14.8
9.7
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
5
22
2.28
1.03
1.6
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
139
1197
1.17
1.02
17.0
9.4
mmol/l
6.4
6.5
0.10
133
1164
(3003396) Base excess in Arterial blood by calculation
122
1040
1.18
1.01
11.0
8.5
mmol/l
1.0
0.8
0.22
92
795
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
23
155
1.49
1.01
1.5
1.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
15
91
1.65
1.00
1.1
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
9
48
1.88
1.00
3.2
1.8
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
7
35
2.00
1.00
2.0
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
48
370
1.30
0.99
1.3
1.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
31
0.00
0.96
0.0
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
569
5348
1.09
0.96
1.8
1.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
26
182
1.43
0.96
1.3
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
27
191
1.42
0.94
1.5
1.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
140
1216
1.16
0.94
13.8
5.6
kpa
5.0
5.1
0.71
131
1156
(3012095) Magnesium [Moles/volume] in Serum or Plasma
231
2077
1.13
0.94
9.2
5.1
mmol/l
0.8
0.8
0.79
219
1966
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
26
183
1.43
0.93
1.3
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
23
158
1.46
0.93
1.9
1.3
nmol/l
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
52
1.73
0.92
1.8
2.8
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
9
52
1.73
0.92
3.0
1.4
ug/l
8.3
8.3
—
9
52
(3005988) Vibrio sp identified in Specimen by Organism specific culture
26
184
1.42
0.91
1.3
1.4
—
—
—
0
0
(4094501)
35
261
1.35
0.91
1.0
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1214
11764
1.07
0.91
3.3
3.0
u/l
33.5
33.9
0.08
1159
11263
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
41
314
1.31
0.90
2.6
2.6
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
8
43
1.86
0.87
7.1
3.0
mmol/l
1.2
1.2
—
8
38
(3009343) pH of Capillary blood
138
1209
1.15
0.85
14.1
5.6
ph
7.4
7.4
—
9
112
(3003740) Influenza virus B Ag [Presence] in Specimen
58
470
1.24
0.84
1.2
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
232
2104
1.12
0.83
2.3
2.3
u/l
5482.7
7151.1
0.38
85
812
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
132
1155
1.15
0.83
1.3
1.3
miu/ml
247.5
235.1
0.16
68
584
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
136
1193
1.15
0.83
14.1
5.6
mmol/l
1.1
1.1
0.15
99
847
(3002523) Influenza virus A Ag [Presence] in Specimen
58
471
1.24
0.82
1.2
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
18
121
1.49
0.82
3.7
4.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
705
6724
1.07
0.81
2.2
2.1
—
—
—
0
0
(4035726)
119
1036
1.16
0.81
1.5
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
465
4367
1.08
0.81
1.6
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
130
1140
1.15
0.80
3.7
3.4
%
22.6
21.8
0.19
48
414
(3023420) DNA double strand Ab [Units/volume] in Serum
27
198
1.37
0.80
1.2
1.6
—
19.3
—
0
8
(3047007) Chlamydophila sp Ab [Presence] in Serum
51
410
1.25
0.80
1.3
1.2
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
24
0.00
0.79
0.0
3.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
48
1.67
0.78
1.0
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
48
1.67
0.78
1.0
2.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
251
1.32
0.78
1.5
1.5
—
—
—
0
0
(3035880) pH of Pleural fluid
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
22
157
1.41
0.76
1.3
1.4
promille
0.6
1.4
1.90
15
127
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
34
1.77
0.76
1.5
2.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
63
522
1.21
0.76
13.4
11.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
12
75
1.60
0.75
1.0
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
16
108
1.49
0.73
1.1
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
8
133
0.60
0.73
2.6
3.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
592
5633
1.07
0.73
2.4
2.4
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
5
25
2.00
0.72
1.2
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
56
1.61
0.72
1.0
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
10
60
1.67
0.72
2.4
2.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
61
508
1.21
0.71
1.1
1.1
u/ml
6.7
7.9
0.20
32
239
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
40
1.75
0.71
1.6
1.9
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
95
824
1.16
0.70
1.2
1.2
u/ml
0.7
2.9
3.26
37
415
(3028679) Herpes simplex virus Ab [Presence] in Serum
20
143
1.40
0.70
1.2
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
161
1448
1.12
0.70
4.1
3.6
ug/l
1.8
1.9
0.16
149
1321
(3015183) Erythrocyte sedimentation rate
9
142
0.63
0.69
1.1
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
73
620
1.18
0.69
3.2
2.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
40
319
1.26
0.69
2.7
2.0
ug/l
3.0
2.1
0.28
35
288
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
31
239
1.30
0.69
5.2
2.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
476
4509
1.07
0.67
4.1
3.1
e6/l
42.9
62.1
0.38
383
3383
(3044242) Glucose [Moles/volume] in Arterial blood
7
43
1.63
0.67
2.4
3.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
144
1291
1.12
0.66
2.0
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
136
1215
1.13
0.66
2.3
2.3
au/ml
28.0
22.2
—
6
98
(3001019) Free T4 and TSH panel - Serum or Plasma
122
1369
0.88
0.65
1.7
1.6
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
10
62
1.62
0.65
1.5
1.1
—
63.7
—
0
14
(4024509)
15
103
1.46
0.65
1.7
1.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
47
386
1.22
0.64
1.1
1.4
—
4.9
—
0
6
(4034850)
54
450
1.21
0.64
7.0
8.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
34
269
1.27
0.64
6.4
5.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
438
4145
1.07
0.63
3.8
3.1
e6/l
0.3
0.3
0.05
355
3058
(3034770) Mitochondria Ab [Titer] in Serum
55
460
1.20
0.63
1.4
1.4
—
1169.2
—
0
13
(40768446) Kidney Pathology biopsy report
13
87
1.50
0.63
3.0
2.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
62
525
1.19
0.63
1.6
1.9
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
19
138
1.38
0.62
1.7
2.0
nmol/l
0.5
0.1
0.54
12
107
(4146454)
11
71
1.55
0.62
2.5
2.9
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
10
63
1.59
0.61
1.5
1.1
—
84.6
—
0
14
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
50
416
1.21
0.61
1.1
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
50
1.60
0.61
1.1
2.0
—
—
—
0
0
(3000012) Reticulocyte production index
8
50
1.60
0.61
1.1
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
126
1402
0.89
0.60
1.4
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
130
1443
0.89
0.59
1.4
1.3
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
14
97
1.45
0.59
2.1
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
28
219
1.28
0.58
12.0
2.8
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
6
36
1.67
0.56
1.3
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
8
55
1.46
0.56
1.9
1.7
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
127
1405
0.90
0.55
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
127
1404
0.90
0.55
1.4
1.4
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
6
38
1.58
0.54
10.7
2.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
246
2295
1.08
0.54
2.0
2.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
35
285
1.23
0.54
1.4
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
30
372
0.80
0.54
2.2
1.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
33
267
1.24
0.54
5.3
4.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
9
61
1.48
0.53
1.0
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
61
1.48
0.53
1.1
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
9
61
1.48
0.53
1.0
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
9
61
1.48
0.53
1.0
1.9
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
67
770
0.87
0.53
2.7
4.1
ug/l
21.7
23.8
0.04
44
564
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
23
294
0.78
0.53
2.0
3.4
u/ml
98.2
888.8
0.84
18
250
(3017704) Immunofixation for Urine
6
39
1.54
0.53
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
127
1399
0.90
0.52
1.4
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
20
152
1.32
0.52
1.1
1.3
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
6
40
1.50
0.51
1.2
1.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
149
1364
1.10
0.51
1.4
1.2
titre
519.1
125.0
0.40
11
33
(44816559) Phosphatidylethanol [Mass/volume] in Blood
40
477
0.84
0.50
1.4
1.3
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
13
92
1.42
0.50
1.2
1.8
—
686592.2
—
0
9
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
6
41
1.46
0.50
1.0
1.1
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
45
380
1.19
0.50
2.1
1.7
—
4.8
—
0
5
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
10
67
1.49
0.49
1.8
1.5
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
34
411
0.82
0.49
1.5
1.6
mmol/l
7.5
7.3
0.31
23
243
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
7
45
1.56
0.49
3.4
2.8
umol/l
31.3
31.5
—
7
35
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
40
335
1.20
0.49
1.1
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
85
757
1.13
0.48
1.3
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
13
93
1.40
0.48
5.5
3.3
u/ml
25.3
61.5
0.96
13
93
(3012516) Albumin [Mass/volume] in Urine
284
2679
1.07
0.48
3.3
3.5
mg/l
754.4
230.9
0.70
176
1795
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
25
199
1.26
0.48
1.5
1.5
—
—
—
0
0
(3020891) Body temperature
45
382
1.18
0.48
5.6
5.1
—
—
—
0
0
(3000492) Spirometry study
179
1659
1.09
0.48
1.3
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
39
327
1.20
0.47
1.4
1.7
g/l
1.0
0.8
0.43
28
251
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
272
1.22
0.47
1.1
1.5
g/l
3.0
3.1
0.31
26
226
(3006184) Hemoglobin [Mass/volume] in Capillary blood
38
318
1.20
0.47
2.0
2.5
g/l
132.7
134.4
0.22
32
258
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
187
2010
0.92
0.47
1.5
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
23
288
0.80
0.46
1.6
1.8
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
58
664
0.87
0.46
1.3
1.3
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
16
120
1.34
0.46
1.1
1.2
u/ml
—
2.7
—
0
10
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
49
1.43
0.46
1.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
13
94
1.39
0.46
6.5
7.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
36
301
1.20
0.45
4.5
3.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
283
1.20
0.45
1.1
1.5
g/l
3.8
3.8
0.03
26
219
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
283
1.20
0.45
1.1
1.5
g/l
7.5
7.4
0.10
26
235
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
283
1.20
0.45
1.1
1.5
—
—
—
0
0
(4027681)
22
174
1.27
0.45
1.1
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
25
202
1.24
0.43
1.3
2.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
93
840
1.11
0.43
3.2
2.4
ug/l
0.7
0.7
0.06
50
447
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
15
113
1.33
0.42
1.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
79
880
0.89
0.42
1.6
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
33
276
1.20
0.42
1.5
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
92
0.65
0.42
1.2
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
81
727
1.12
0.42
1.8
1.7
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
19
149
1.28
0.41
1.1
1.2
u/ml
1.3
9.6
—
10
104
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
176
1.25
0.41
1.3
1.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
64
567
1.13
0.41
1.5
1.5
nmol/l
0.6
0.4
0.27
52
469
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
27
222
1.22
0.41
1.9
2.1
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
0
17
0.00
0.40
0.0
1.2
—
57.9
—
0
5
(3033799) Differential panel - Peritoneal fluid
0
17
0.00
0.40
0.0
2.0
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
17
0.00
0.40
0.0
1.3
—
16.6
—
0
17
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
17
0.00
0.40
0.0
2.6
—
4598.4
—
0
17
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
16
205
0.78
0.40
1.2
2.4
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
8
60
1.33
0.40
1.3
1.1
u/l
17.6
14.7
—
8
51
(3003338) MCHC [Mass/volume]
1661
16434
1.05
0.40
16.2
12.5
g/l
333.6
333.4
0.22
1643
16286
(3009542) Hematocrit [Volume Fraction] of Blood
1774
17581
1.05
0.39
13.8
10.9
%
39.8
40.0
0.84
1416
14663
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
104
0.67
0.39
1.0
1.2
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
5
35
1.43
0.39
3.8
2.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
294
2799
1.06
0.39
3.7
4.2
mg/mmol
11.5
17.0
0.29
187
1879
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
23
187
1.23
0.39
2.0
1.3
nmol/l
—
0.6
—
0
5
(4268621)
17
214
0.79
0.38
2.2
2.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
306
2921
1.06
0.37
2.0
1.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
131
1215
1.08
0.37
2.5
2.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
84
763
1.11
0.37
1.3
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
15
116
1.30
0.37
1.5
1.6
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
26
216
1.21
0.37
1.2
1.4
g/l
3.4
2.7
1.05
19
154
(3024139) IgG subclass 3 [Mass/volume] in Serum
26
216
1.21
0.37
1.2
1.4
g/l
0.4
0.4
0.05
20
153
(3027135) IgG subclass 1 [Mass/volume] in Serum
26
216
1.21
0.37
1.2
1.4
g/l
7.0
6.2
1.00
20
154
(3033658) Prothrombin time (PT) actual/Normal
390
3750
1.05
0.36
4.9
4.3
%
92.3
94.4
1.07
374
3653
(3051387) C reactive protein [Mass/volume] in Capillary blood
36
309
1.17
0.36
3.1
3.2
mg/l
18.1
25.1
1.10
22
188
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
11
81
1.36
0.36
1.1
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
106
1150
0.92
0.36
1.5
1.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
9
71
1.27
0.36
1.4
1.6
nmol/l
134.0
135.7
—
9
71
(3024932) HLA-DR beta [Type]
9
71
1.27
0.36
1.1
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
12
157
0.76
0.35
1.3
1.5
umol/l
7.8
10.1
1.79
12
148
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
42
1.43
0.35
1.3
1.5
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
5
79
0.63
0.35
1.0
1.1
u/ml
0.6
6.7
—
5
67
(3035320) C reactive protein [Mass/volume] in Body fluid
17
135
1.26
0.35
1.5
2.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
17
135
1.26
0.35
1.1
3.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
16
126
1.27
0.35
1.1
1.5
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
16
126
1.27
0.35
2.7
4.5
—
120.5
—
0
18
(3021879) Hepatitis B virus core Ab [Presence] in Serum
204
1929
1.06
0.35
1.6
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
43
376
1.15
0.35
1.6
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
52
585
0.89
0.35
1.3
1.9
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
29
341
0.85
0.35
2.4
2.5
nmol/l
0.8
0.7
0.01
23
293
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
143
1529
0.93
0.34
1.4
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
108
998
1.09
0.34
1.8
2.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
26
218
1.20
0.34
1.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
123
1144
1.08
0.34
1.4
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
57
510
1.12
0.33
1.8
2.0
iu/l
173.7
4.6
0.48
19
204
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
13
100
1.30
0.33
2.5
2.7
%
46.4
44.6
—
5
29
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
57
635
0.89
0.33
1.7
1.5
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
14
177
0.79
0.33
1.0
1.3
—
30.2
—
0
6
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
26
219
1.19
0.33
1.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
88
0.68
0.33
1.2
1.3
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
11
83
1.33
0.32
2.9
2.2
nmol/l
155.5
154.2
0.01
11
75
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
62
560
1.11
0.32
1.2
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
92
1.31
0.31
2.0
2.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
170
1605
1.06
0.31
3.5
3.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
20
165
1.21
0.31
1.1
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
190
1802
1.06
0.31
1.4
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
20
166
1.21
0.29
1.1
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
160
1512
1.06
0.29
1.3
1.4
—
—
—
0
0
(44813793)
23
194
1.19
0.29
1.1
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
7
56
1.25
0.29
2.0
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
81
746
1.09
0.29
1.2
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
7
57
1.23
0.29
1.3
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
105
1125
0.93
0.28
1.4
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
20
167
1.20
0.28
1.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
13
103
1.26
0.28
1.5
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
19
158
1.20
0.28
1.1
1.8
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
33
289
1.14
0.28
4.2
3.3
umol/l
33.9
33.0
0.10
28
261
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
222
2320
0.95
0.28
3.5
2.8
e6/l
4.2
3.7
0.25
137
1193
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
22
186
1.18
0.28
1.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
25
214
1.17
0.28
1.2
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
61
556
1.10
0.27
1.1
1.1
u/ml
4.6
5.3
0.13
34
243
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
8
63
1.27
0.27
1.3
1.1
u/l
711.4
72.1
—
8
54
(40768800) Prostate Pathology biopsy report
8
63
1.27
0.27
1.4
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
105
1122
0.93
0.27
1.4
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
62
567
1.10
0.26
1.2
1.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
8
66
1.21
0.26
6.0
5.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
8
66
1.21
0.26
3.0
2.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
88
818
1.08
0.26
2.1
2.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
51
562
0.91
0.26
1.2
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
104
1.25
0.26
1.3
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
20
169
1.19
0.25
2.1
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
9
72
1.25
0.25
1.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
19
160
1.19
0.25
1.1
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
22
188
1.17
0.25
2.0
1.7
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
15
123
1.22
0.25
1.9
1.8
mg/l
35.3
20.0
—
6
39
(3006462) Nitrate [Presence] in Urine
9
77
1.17
0.24
2.7
2.6
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
6
81
0.74
0.24
1.0
1.1
u/ml
7.8
2.9
—
6
66
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
6
84
0.71
0.24
1.2
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
21
180
1.17
0.23
1.1
1.3
—
—
—
0
0
(4133840)
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
28
247
1.14
0.22
1.3
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11
88
1.25
0.22
1.3
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
11
88
1.25
0.22
1.2
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
92
0.76
0.22
2.1
1.7
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
2.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
62
575
1.08
0.21
1.2
1.2
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
12
0.00
0.21
0.0
2.5
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.3
—
36.8
—
0
12
(4062490)
25
220
1.14
0.21
1.2
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
20
173
1.16
0.21
1.1
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
89
1.24
0.21
1.2
1.7
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
13
0.00
0.21
0.0
2.8
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
22
251
0.88
0.21
2.3
2.6
%
16.6
17.5
0.99
14
140
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
35
316
1.11
0.20
1.1
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
152
1457
1.05
0.19
1.7
2.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
51
471
1.08
0.19
1.6
1.8
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
15
127
1.18
0.19
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
74
695
1.07
0.19
1.6
1.7
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
31
343
0.90
0.19
1.5
1.5
mmol/l
5.9
6.7
1.20
20
231
(40765089) Chromosome analysis panel - Blood by G-banded
18
156
1.16
0.18
1.0
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
36
328
1.10
0.18
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
21
237
0.88
0.17
2.5
3.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
106
1011
1.05
0.17
2.2
2.3
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
25
224
1.12
0.17
1.1
1.1
iu/ml
2.0
7.6
—
9
54
(1002224) Polysomnography panel
66
701
0.94
0.17
1.2
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
57
608
0.94
0.16
1.4
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
12
101
1.19
0.16
3.3
4.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
113
1082
1.05
0.16
1.1
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
12
141
0.85
0.16
1.2
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
14
120
1.17
0.16
1.4
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
27
244
1.11
0.16
1.1
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
183
0.87
0.16
1.7
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
130
0.85
0.16
1.4
1.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
13
151
0.86
0.15
1.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
35
380
0.92
0.15
1.2
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
78
1.15
0.15
12.0
2.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
78
1.15
0.15
12.0
2.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
238
2443
0.97
0.15
1.2
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
129
0.85
0.14
1.2
1.8
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
15
131
1.15
0.14
1.2
1.4
ug/l
4.0
5.5
1.83
15
108
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
8
97
0.82
0.13
1.0
1.4
—
74.1
—
0
10
(3044290) Cell count panel - Cerebral spinal fluid
39
418
0.93
0.13
1.7
2.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
131
1266
1.04
0.13
1.9
1.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
247
2414
1.03
0.13
3.3
2.6
e6/l
0.8
1.2
1.07
161
1289
(3024891) Influenza virus A+B Ag [Presence] in Specimen
65
618
1.05
0.13
1.2
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
18
161
1.12
0.13
1.3
1.4
u/ml
0.2
0.5
—
10
48
(3038177) Helicobacter pylori Ab [Presence] in Serum
37
345
1.07
0.12
1.1
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
11
127
0.87
0.12
1.0
1.1
miu/ml
2347.0
1410.3
1.17
11
127
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
36
385
0.93
0.12
1.6
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
18
162
1.11
0.11
1.6
1.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
18
162
1.11
0.11
2.8
2.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
366
3601
1.02
0.11
2.2
2.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
22
201
1.10
0.11
1.4
1.6
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
33
308
1.07
0.11
1.2
1.3
u/ml
2.2
4.9
1.43
14
111
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
86
1.16
0.11
1.8
1.2
—
—
—
0
0
(4306422)
32
299
1.07
0.10
1.3
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
25
270
0.93
0.10
15.9
6.7
u/ml
0.3
0.4
1.08
20
150
(21494434) Karyotype in Bone marrow
11
96
1.15
0.10
1.2
1.3
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
5
45
1.11
0.09
1.0
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
48
1.04
0.09
1.8
2.2
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
6
54
1.11
0.09
1.2
1.0
kpa
3.0
3.2
—
6
43
(3006598) pH of Arterial cord blood
6
55
1.09
0.09
1.2
1.0
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
6
55
1.09
0.09
1.2
1.0
kpa
7.0
7.3
—
6
44
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
66
684
0.96
0.08
1.1
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
63
0.79
0.08
1.0
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
5
64
0.78
0.08
1.4
1.1
—
58.0
—
0
11
(4198724)
18
195
0.92
0.08
2.0
2.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
7
65
1.08
0.08
1.1
1.1
u/ml
15.6
48.7
—
7
65
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
275
2788
0.98
0.07
1.5
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
131
1282
1.02
0.07
2.1
2.7
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
77
1.04
0.07
1.1
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
78
1.03
0.07
1.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
78
1.03
0.07
1.0
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
44
422
1.04
0.07
1.3
1.2
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
7
85
0.82
0.07
1.3
1.2
%
108.9
109.8
—
7
73
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
86
1.05
0.07
4.6
3.9
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
8
92
0.87
0.06
1.4
1.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
8
93
0.86
0.06
1.1
1.1
%
79.4
87.1
—
8
93
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
93
0.86
0.06
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
154
1567
0.98
0.06
1.1
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
102
0.88
0.06
1.0
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
33
316
1.05
0.05
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
33
316
1.05
0.05
1.4
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
178
1805
0.98
0.05
1.7
1.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
90
1.11
0.05
1.7
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
78
763
1.02
0.05
1.1
1.1
u/ml
6.1
7.3
0.23
44
471
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
13
120
1.08
0.05
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
13
120
1.08
0.05
1.2
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
636
6391
0.99
0.04
1.7
1.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
46
447
1.03
0.04
1.1
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
75
735
1.02
0.04
1.1
1.1
u/ml
0.6
1.2
0.98
32
395
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
93
914
1.02
0.04
1.8
1.6
mg/l
3.3
4.5
0.72
62
613
(40768795) Lymph node Pathology biopsy report
10
109
0.92
0.04
1.0
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
177
1789
0.99
0.04
1.2
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
29
279
1.04
0.04
4.4
4.5
mmol/l
1.8
2.1
0.25
14
158
(3010726) Horse dander IgE Ab [Units/volume] in Serum
71
724
0.98
0.03
1.1
1.1
u/ml
1.0
3.2
3.01
23
206
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
13
121
1.07
0.03
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
30
311
0.96
0.03
1.3
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
621
6187
1.01
0.03
2.3
2.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
108
0.93
0.03
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
23
221
1.04
0.03
1.2
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
13
122
1.07
0.02
13.3
8.1
%
12.2
11.5
0.29
13
122
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
136
1347
1.01
0.02
1.6
1.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
114
1128
1.01
0.02
1.4
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
25
242
1.03
0.02
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
470
4685
1.00
0.02
1.9
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
98
990
0.99
0.02
11.4
12.8
inr
1.0
1.2
2.61
25
167
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
100
1010
0.99
0.02
2.3
2.4
ml/min/173m2
83.0
79.2
0.32
36
373
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
31
302
1.03
0.02
2.0
1.6
—
1960.0
—
0
8
(3028300) Cannabinoids [Presence] in Urine
183
1839
0.99
0.01
1.7
2.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
45
443
1.02
0.01
1.7
2.3
e6/l
27.0
16.8
0.17
36
343
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
15
156
0.96
0.00
1.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
171
1703
1.00
0.00
1.7
2.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
38
386
0.98
0.00
1.1
1.1
u/ml
2.5
2.8
0.10
23
173
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
45
444
1.01
0.00
1.7
2.4
e6/l
345.8
9198.6
0.55
37
360
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
48
474
1.01
0.00
1.0
1.1
u/ml
2.9
0.4
—
9
136
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
14
135
1.04
0.00
1.0
1.1
u/l
1.0
1.0
—
5
61
(3040151) Glucose [Moles/volume] in Capillary blood
15
149
1.01
0.00
1.3
7.3
mmol/l
5.9
6.3
—
8
124
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
17
169
1.01
0.00
1.3
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
81
811
1.00
0.00
1.4
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
106
1.04
0.00
1.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
12
124
0.97
0.00
1.2
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
14
136
1.03
0.00
1.1
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
14
136
1.03
0.00
1.9
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
33
334
0.99
0.00
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
31
308
1.01
0.00
1.3
1.3
u/ml
2.2
4.5
1.93
12
139
(3000764) Benzodiazepines [Presence] in Urine
182
1822
1.00
0.00
1.7
2.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
10
97
1.03
0.00
1.1
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
183
1833
1.00
0.00
1.7
2.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032333) Phosphate [Mass or Moles] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
6
61
0.98
0.00
1.0
1.0
mu/l
7.2
9.0
—
6
50
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
194.6
—
0
5
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
60
1.00
0.00
1.0
1.1
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4212803)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002481) Calcium/Creatinine [Mass Ratio] in Urine
0
6
0.00
0.00
0.0
5.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
57
0.88
0.00
1.0
1.1
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
90
1.00
0.00
1.2
1.7
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
93
0.97
0.00
3.8
3.0
u/ml
1383.2
710.8
—
9
93
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
106.7
—
0
7
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
90
1.00
0.00
1.1
1.2
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
7
0.00
0.00
0.0
5.9
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
6
61
0.98
0.00
1.0
1.2
—
17.2
—
0
14
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
9
90
1.00
0.00
2.7
2.5
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.6
—
0.3
—
0
5
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026820) Hemoglobin [Mass/volume] in Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
162.2
—
0
5
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3012932) Hazelnut IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
23.1
—
0
5
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
51
0.98
0.00
2.2
1.6
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
12
120
1.00
0.00
1.4
1.5
g/l
1.0
1.0
0.06
12
120
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
-0.00
0.0
1.1
—
29.4
—
0
8
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3025315) Body weight
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint K11_OPEN_BITE and mortality.

Females

Parameter HR [95% CI] p-value
K11_OPEN_BITE 1.305 [1.01, 1.68] 0.04
Birth year 0.992 [0.98, 1.0] 0.077

During the follow-up period (1.1.1998 — 31.12.2019), 94 out of 16248 females with K11_OPEN_BITE died.

Males

Parameter HR [95% CI] p-value
K11_OPEN_BITE 1.104 [0.83, 1.47] 0.499
Birth year 0.987 [0.98, 1.0] 0.008

During the follow-up period (1.1.1998 — 31.12.2019), 83 out of 11181 males with K11_OPEN_BITE died.

Mortality risk

Mortality risk for people of age

years, who have K11_OPEN_BITE.

N-year risk Females Males
1 0.081% 0.199%
5 0.619% 1.139%
10 1.679% 2.966%
15 3.275% 5.819%
20 5.607% 9.616%

Relationships between endpoints

↥

Index endpoint: K11_OPEN_BITE – Open bite

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data